IDH1 and chondrosarcoma: From this analysis, we found medium- and long-chain lipid-derived acylcarnitines, C10, C16, and C16:1-OH/C14:1-DC significantly elevated in mutant IDH1 chondrosarcomas compared with non-mutant chondrosarcomas (Table 3).